Cingulate Inc.
CINGNASDAQHealthcare● Active
$4.53
+$0.04(+0.78%)
Market Cap$25395352
P/E Ratio—
52W High$11.89
52W Low$3.16
Cingulate Inc. (CING) Earnings: Dates, EPS & Revenue History
Quarterly EPS vs. estimates, revenue surprises, next earnings date, and analyst consensus.
CING · earnings · updated Jun 8, 2026
Latest Earnings
Q2 FY2026Report Date: May 14, 2026EPS Actual
-$0.95
Est. -$0.53 · -79.3%
Revenue
—
Fiscal Period
Q2 FY2026
FY ends December
Report Date
May 14, 2026
After Market Close
▼ Miss EPS
CING reports quarterly as a NASDAQ-listed Biotechnology company. Fiscal year ends in December. Data: FMP · Updated hourly.
Next Earnings Date
Days Away
85
days
Expected Date
Sep 1, 2026
Fiscal Period
Q3 FY2026
Release Time
◌ Time TBD (Unconfirmed)EPS Est.
$0.21
Rev. $0.66B
Days Away85
Expected DateSep 1, 2026
Fiscal PeriodQ3 FY2026
Release TimeTime TBD (Unconfirmed)
EPS Est.$0.21
Rev. Est.$0.66B
EPS & Revenue vs. Estimates
Actual (Beat)
Actual (Miss)
Estimated
Earnings History
| Period | Report Date | EPS Est. | EPS Actual | EPS Surpr. | Revenue | Rev. Est. | Rev. Surpr. |
|---|---|---|---|---|---|---|---|
| ◌ Q3 FY2026 | Aug 18, 2026 | -$0.65 | — | — | — | $0.00B | — |
| ▼ Q2 FY2026 | May 14, 2026 | -$0.53 | -$0.95 | -79.3% | — | — | — |
| ▼ Q1 FY2026 | Mar 18, 2026 | -$0.56 | -$0.84 | -50.0% | — | — | — |
| ▼ Q4 FY2025 | Nov 13, 2025 | -$0.80 | -$1.35 | -68.8% | — | — | — |
| ▼ Q3 FY2025 | Aug 19, 2025 | -$0.82 | -$1.09 | -32.9% | — | — | — |
| ▼ Q2 FY2025 | May 8, 2025 | -$1.00 | -$1.04 | -4.0% | — | — | — |
| ▲ Q1 FY2025 | Mar 27, 2025 | -$1.48 | -$0.14 | +90.5% | — | — | — |
| ▲ Q4 FY2024 | Nov 7, 2024 | -$2.22 | -$1.83 | +17.6% | — | — | — |
Q3 FY2026
Aug 18, 2026
EPS Actual
—
EPS Est.
-$0.65
EPS Surpr.
—
Revenue
—
Q2 FY2026
May 14, 2026Miss
EPS Actual
-$0.95
EPS Est.
-$0.53
EPS Surpr.
-79.3%
Revenue
—
Q1 FY2026
Mar 18, 2026Miss
EPS Actual
-$0.84
EPS Est.
-$0.56
EPS Surpr.
-50.0%
Revenue
—
Q4 FY2025
Nov 13, 2025Miss
EPS Actual
-$1.35
EPS Est.
-$0.80
EPS Surpr.
-68.8%
Revenue
—
Q3 FY2025
Aug 19, 2025Miss
EPS Actual
-$1.09
EPS Est.
-$0.82
EPS Surpr.
-32.9%
Revenue
—
Q2 FY2025
May 8, 2025Miss
EPS Actual
-$1.04
EPS Est.
-$1.00
EPS Surpr.
-4.0%
Revenue
—
Q1 FY2025
Mar 27, 2025Beat
EPS Actual
-$0.14
EPS Est.
-$1.48
EPS Surpr.
+90.5%
Revenue
—
Q4 FY2024
Nov 7, 2024Beat
EPS Actual
-$1.83
EPS Est.
-$2.22
EPS Surpr.
+17.6%
Revenue
—
Analyst Estimates
Limited analyst coverage (fewer than 3 analysts). Estimates may not reflect market consensus.
EPS Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $-0.20 | $-0.20 | $-0.20 | 2 |
| Q3 FY2027 | $-0.26 | $-0.26 | $-0.26 | 1 |
| Q2 FY2027 | $-0.28 | $-0.28 | $-0.28 | 1 |
| Q1 FY2027 | $-0.35 | $-0.35 | $-0.35 | 2 |
| Q4 FY2026 | $-0.45 | $-0.45 | $-0.45 | 2 |
| Q3 FY2026 | $-0.75 | $-0.59 | $-0.38 | 4 |
Revenue Estimates
| Period | Low | Consensus | High | # Analysts |
|---|---|---|---|---|
| Q4 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
| Q3 FY2027 | $0.0B | $0.0B | $0.0B | 2 |
| Q2 FY2027 | $0.0B | $0.0B | $0.0B | 2 |
| Q1 FY2027 | $0.0B | $0.0B | $0.0B | 1 |
| Q4 FY2026 | $0.0B | $0.0B | $0.0B | 2 |
| Q3 FY2026 | $0.0B | $0.0B | $0.0B | 3 |
Earnings Price Reaction
Closing price one trading day before vs. one trading day after each earnings release.
| Period | Report Date | EPS Beat/Miss | Price Before | Price After | 1D Reaction |
|---|---|---|---|---|---|
| ▼ Q2 FY2026 | May 14, 2026 | -79.3% | $4.92 | $4.39 | -10.77% |
| ▼ Q1 FY2026 | Mar 18, 2026 | -50.0% | $11.66 | $8.04 | -31.05% |
| ▼ Q4 FY2025 | Nov 13, 2025 | -68.8% | $3.80 | $3.33 | -12.37% |
| ▼ Q3 FY2025 | Aug 19, 2025 | -32.9% | $4.16 | $3.76 | -9.62% |
| ▼ Q2 FY2025 | May 8, 2025 | -4.0% | $3.94 | $4.09 | +3.81% |
| ▲ Q1 FY2025 | Mar 27, 2025 | +90.5% | $4.14 | $4.35 | +5.07% |
| ▲ Q4 FY2024 | Nov 7, 2024 | +17.6% | $3.36 | $3.44 | +2.38% |
| ▲ Q3 FY2024 | Aug 13, 2024 | +3.0% | $2.85 | $2.25 | -21.05% |
Q2 FY2026-10.77%
Report Date
May 14, 2026
EPS Beat/Miss
-79.3%
Price Before
$4.92
Price After
$4.39
Q1 FY2026-31.05%
Report Date
Mar 18, 2026
EPS Beat/Miss
-50.0%
Price Before
$11.66
Price After
$8.04
Q4 FY2025-12.37%
Report Date
Nov 13, 2025
EPS Beat/Miss
-68.8%
Price Before
$3.80
Price After
$3.33
Q3 FY2025-9.62%
Report Date
Aug 19, 2025
EPS Beat/Miss
-32.9%
Price Before
$4.16
Price After
$3.76
Q2 FY2025+3.81%
Report Date
May 8, 2025
EPS Beat/Miss
-4.0%
Price Before
$3.94
Price After
$4.09
Q1 FY2025+5.07%
Report Date
Mar 27, 2025
EPS Beat/Miss
+90.5%
Price Before
$4.14
Price After
$4.35
Q4 FY2024+2.38%
Report Date
Nov 7, 2024
EPS Beat/Miss
+17.6%
Price Before
$3.36
Price After
$3.44
Q3 FY2024-21.05%
Report Date
Aug 13, 2024
EPS Beat/Miss
+3.0%
Price Before
$2.85
Price After
$2.25
Avg Beat Reaction-4.53%
Avg Miss Reaction-12.00%
Beat Rate3 / 8 quarters
Largest Move-31.05% (Q1 FY2026)
Data: FMP /historical-price-eod/full · field: close
About Earnings & Data Methodology
Data source: Financial Modeling Prep (FMP) | Updated: Hourly | Surprise%: (Actual − Estimate) / |Estimate| × 100 | Fiscal year: CING ends December
Cingulate Inc. (CING) most recently reported earnings on May 14, 2026 for Q2 FY2026, posting EPS of $-0.95 — missing the analyst consensus of $-0.53 by -79.3%. The next CING earnings date is expected around September 1, 2026.
Each quarter, investors track CING earnings for signals on forward guidance and business momentum. For longer-term revenue trends, see the Revenue tab. CING revenue tab →
Earnings Glossary
EPS (Earnings Per Share)
Net income ÷ diluted shares outstanding. The primary metric analysts use to gauge quarterly profitability.
Earnings Surprise %
(Actual − Estimate) / |Estimate| × 100. Positive = Beat. Negative = Miss.
Beat / Miss / In-Line
Beat = Actual ≥ Estimate. Miss = Actual < Estimate. In-Line = within ±1%.
BMO / AMC
Before Market Open / After Market Close. Two windows when companies typically release results.
Fiscal Quarter
CING's fiscal year ends in December. Fiscal quarters may not align with calendar quarters.
Analyst Consensus
Average EPS/Revenue forecast across all covering analysts. More analysts = more reliable estimate.
Figures tie to FMP earnings calendar, estimates, and SEC 10-Q/10-K filings where noted.
Frequently asked questions
CING earnings · 5 questionsCingulate Inc.'s next earnings report is expected around September 1, 2026. CING typically reports quarterly — approximately every three months. The exact date is confirmed by the company 2–4 weeks before the release. Time is currently TBD; CING historically reports after market close (AMC).
CING earnings datewhen is CING earningsCING next earnings datewhen does CING report earningsCING earnings calendar
▸ Source: FMP · Cingulate Inc. SEC filings · US GAAP · Cingulate Inc. SEC 10-K & 10-Q filings · US GAAP · Updated: Jun 8, 2026